Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).

被引：0
|
作者：
Lyons, Roger M. [1 ]
Boccia, Ralph V. [2 ]
Macik, Gail [3 ]
Mandanas, Romeo A. [4 ]
Wang, Xuena [5 ]
Lizambri, Richard [6 ]
Berger, Dietmar [5 ]
机构：
[1] Canc Care Ctr S Texas US Oncol, San Antonio, TX USA
[2] Ctr Canc & Blood Disorders, Bethesda, MD USA
[3] Univ Virginia, Charlottesville, VA USA
[4] Canc Care Associates W, Oklahoma City, OK USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Amgen Inc, Oncol Dev, Thousand Oaks, CA USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1362 / 1362
页数：1
相关论文
共 50 条
  • [1] Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience
    Pasquet, Marlene
    Aladjidi, Nathalie
    Guiton, Corinne
    Courcoux, Mary-France
    Munzer, Martine
    Auvrignon, Anne
    Lutz, Patrick
    Ducassou, Stephane
    LeRoy, Gwennaelle
    Munzer, Caroline
    Leverger, Guy
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (02) : 266 - 271
  • [2] Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)
    Liebman, Howard
    Henry, David
    Lefrere, Francois
    Viallard, Jean-Francois
    Lichtin, Alan
    George, James
    Sanz, Miguel
    Zhang, Kathy
    Rutstein, Mark
    [J]. BLOOD, 2008, 112 (11) : 1171 - 1171
  • [3] SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)
    Rodeghiero, F.
    Provan, D.
    Cines, D.
    Stasi, R.
    Tarantino, M.
    Nie, K.
    Jun, S.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 73 - 74
  • [4] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    David J. Kuter
    Cynthia Macahilig
    Kelly M. Grotzinger
    Sara A. Poston
    Peter Feng Wang
    Katie L. Dawson
    Melea Ward
    [J]. International Journal of Hematology, 2015, 101 : 255 - 263
  • [5] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    Kuter, David J.
    Macahilig, Cynthia
    Grotzinger, Kelly M.
    Poston, Sara A.
    Wang, Peter Feng
    Dawson, Katie L.
    Ward, Melea
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 255 - 263
  • [6] ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Cines, D.
    Wasser, J.
    Rodeghiero, F.
    Chong, B.
    Steurer, M.
    Provan, D.
    Lyons, R.
    Garcia Chavez, J.
    Carpenter, N.
    Wang, X.
    Eisen, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 194 - 194
  • [7] Romiplostim: A Bridge To Splenectomy In Three Patients With Refractory Immune Thrombocytopenia (ITP)
    Shah, Dhaval
    Rambally, Siayareh
    Mims, Martha
    Udden, Mark M.
    [J]. BLOOD, 2013, 122 (21)
  • [8] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    [J]. HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [9] A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO
    Arocho, R.
    Northridge, K.
    Rivera Hurtado, R.
    Garcia Chavez, J.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A62 - A62
  • [10] Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Wasser, Jeffrey
    Godeau, Bertrand
    Provan, Andrew
    Lyons, Roger M.
    Altomare, Ivy
    Wang, Xuena
    Woodard, Paul
    [J]. BLOOD, 2012, 120 (21)
12345